Acta Neuropathologica Communications · 2018 · 11 citations · 74 references
MedicineNeurobiologyNeuroscienceCell SignalingMolecular NeuroscienceSignal TransductionGlial Cell BiologyGlial Cell Molecular BiologyGlial Cell ProliferationGlial PathologyPeripheral Nerve TumorsSchwann Cell BiologyAtp Release SignalingBeta-arrestin SignalingBeta-arrestin-mediated RegulationBeta-arrestin-mediated SignalingCell Cycle DynamicsCell Cycle InhibitionNeurofibromatosis Type 1Schwann Cell Proliferation
Normal Schwann cells (SCs) are quiescent in adult nerves, when ATP is released from the nerve in an activity dependent manner. We find that suppressing nerve activity in adult nerves causes SC to enter the cell cycle. In vitro, ATP activates the SC G-protein coupled receptor (GPCR) P2Y2. Downstream of P2Y2, β-arrestin-mediated signaling results in PP2-mediated de-phosphorylation of AKT, and PP2 activity is required for SC growth suppression. NF1 deficient SC show reduced growth suppression by ATP, and are resistant to the effects of β-arrestin-mediated signaling, including PP2-mediated de-phosphorylation of AKT. In patients with the disorder Neurofibromatosis type 1, NF1 mutant SCs proliferate and form SC tumors called neurofibromas. Elevating ATP levels in vivo reduced neurofibroma cell proliferation. Thus, the low proliferation characteristic of differentiated adult peripheral nerve may require ongoing, nerve activity-dependent, ATP. Additionally, we identify a mechanism through which NF1 SCs may evade growth suppression in nerve tumors.
74
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Michael R. Elliott, Faraaz B. Chekeni, Paul C. Trampont et al. · Nature · 2009 · 1.6K citations · Full text
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh Marcus et al. · New England Journal of Medicine · 2016 · 665 citations · Full text